Field
The present disclosure relates to a balloon catheter system and method for treating biological vessels and, more particularly, to an angioplasty balloon catheter which includes a grid of fibers attached to, or integrated within a wall of the balloon. The fibers are less elastic than the balloon material and as such, when the balloon is inflated beyond a predetermined pressure a plurality of balloon regions protrude from the grid formed by the fibers.
Description of the Related Art
Percutaneous transluminal angioplasty (PTA) is a procedure in which a balloon catheter is inserted through an artery and guided to the region of lumen narrowing. The balloon is inflated to force the plaque material (typically fat and calcium) against the wall of the artery to open the vessel lumen and improve blood flow.
Angioplasty balloons are typically cylindrical when inflated and have different lengths and diameters to conform to different vessel sizes. The balloons are inflated at high pressure, normally between 8-20 atmospheres, in order to overcome the resistance of the plaque and achieve luminal expansion.
Standard balloons (also referred to as plain balloons) are the most commonly used technique for dilation of a lesion in a blood vessel (angioplasty); however, standard balloons suffer from several disadvantages.
Since the diameter and composition of stenotic regions of an artery are not typically uniform, inflation of a standard balloon in a vessel leads to non-uniform (axially and radially) expansion. Variability in the lesion composition (lesions can be composed of a mixture of hard and soft plaque material) will lead to variability in resistance to dilation along the lesion and to balloon over expansion in the least resistant regions of the vessel. As a result, standard balloons can apply excessive forces to less resistant regions of the lesion thus traumatizing the vessel wall (e.g. dissections) and yet do not apply enough forces to resistant plaque regions to enable effective dilation thereof.
Trauma to the vessel wall is associated with poor long term clinical results and can accelerate or induce restenosis in the treated areas. In addition, major dissections, such as flow limiting dissections require stenting further complicating the procedure.
Attempts to solve the aforementioned limitations of standard balloon catheters by increasing forces on resistant plaque region via cutting or scoring elements (blades/wires) positioned on the balloon surface (e.g. U.S. Publication No. 20040143287 and U.S. Publication No. 20060085025) were somewhat successful but did not adequately solve problems resulting from non-uniform balloon expansion. In addition, cutting and scoring balloons are not designed to avoid traumatizing the vessel walls, but instead to control the trauma to the vessel walls by inducing controlled and predictable dissections.
Thus, there is a need for a high pressure angioplasty balloon catheter capable of effectively opening resistant plaque regions without traumatizing the vessel walls in less resistant plaque regions.
According to one aspect of the present disclosure, there is provided a system for dilating a stenosed vessel comprising: (a) a balloon mounted on a catheter shaft, the balloon being composed of a first material; and (b) a plurality of fibers forming a grid attached to a surface of the balloon or integrated within a wall thereof, the plurality of fibers being composed of a second material having less elasticity than the first material such that when the balloon is inflated beyond a predetermined pressure a plurality of balloon regions protrude from the grid formed by the plurality of fibers.
According to further features of the disclosure described below, the balloon is composed of a first polymer, and the plurality of fibers are composed of a second polymer.
According to still further features in the described embodiments, a thickness of each of the plurality of fibers is selected from a range of 10-750 microns.
According to still further features in the described embodiments, a thickness of each of the plurality of fibers varies along its length.
According to still further features in the described embodiments, the grid forms a plurality of cells having an area selected from a range of 1-25 mm2.
According to still further features in the described embodiments, the grid is attached to a surface of the balloon via an adhesive.
According to still further features in the described embodiments, the grid is attached to a surface of the balloon via welding.
According to still further features in the described embodiments, a tensile modulus of each of the plurality of fibers is selected from a range of 1-150 GPa and the tensile modulus of the balloon is selected from a range of 0.0002-0.0100 GPa.
According to still further features in the described embodiments, the cells include triangular or diamond-shaped cells or both.
According to still further features in the described embodiments, a lead angle of the cells is selected from a range of 30-180 degrees.
According to still further features in the described embodiments, a linear mass density of each of the plurality of fibers is 1-100 Denier.
According to still further features in the described embodiments, a linear mass density of each of the plurality of fibers is 50 Denier.
According to still further features in the described embodiments, the grid pattern is formed from N fibers helically wound around the balloon in a clockwise direction and N fibers helically wound around the balloon in a counterclockwise direction. The balloon can optionally include L longitudinal fibers, wherein L can be 2 or more.
According to still further features in the described embodiments, N is selected from a range of 4-16.
According to still further features in the described embodiments, N is 4.
According to still further features in the described embodiments, the predetermined pressure is at least 2 atmospheres.
According to still further features in the described embodiments, the plurality of isolated balloon regions protrude at least 0.1 mm from the surface when the balloon is inflated to its working pressure (e.g. 5-25 ATMs).
According to still further features in the described embodiments, the grid is sandwiched between the balloon and a layer of material.
According to still further features in the described embodiments, each of the plurality of fibers is a monofilament fiber.
According to still further features in the described embodiments, each of the plurality of fibers is a multifilament fiber.
According to still further features in the described embodiments, each of the plurality of fibers is composed of polypropylene, PLLA, PEEK, aramids (Kevlar®), polyester fibers (Dacron®), aromatic polyesters (Vectran®), aliphatic polyamides (nylons) and/or ultra-high molecular weight polyethylene.
According to still further features in the described embodiments, the balloon and/or the plurality of fibers are coated with a drug-containing formulation.
According to still further features in the described embodiments, the drug is an antiproliferative drug.
The present disclosure successfully addresses the shortcomings of the presently known configurations by providing a balloon catheter system, which can be used to open stenosed vessels without traumatizing the vessel wall.
Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present disclosure, suitable methods, and materials are described below. In case of conflict, the patent specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and not intended to be limiting.
The disclosure is herein described, by way of example only, with reference to the accompanying drawings. With specific reference now to the drawings in detail, it is stressed that the particulars shown are by way of example and for purposes of illustrative discussion of the embodiments of the present disclosure only, and are presented in the cause of providing what is believed to be the most useful and readily understood description of the principles and conceptual aspects of the disclosure. In this regard, no attempt is made to show structural details of the disclosure in more detail than is necessary for a fundamental understanding of the disclosure, the description taken with the drawings making apparent to those skilled in the art how the several forms of the disclosure may be embodied in practice.
The present disclosure relates to a balloon catheter system, which is capable of applying uniform pressure to a vessel wall even under high inflation pressures and as such can be used to dilate stenosed regions of a body vessel such as an artery while applying a uniform expansion force to all portions of the treated vessel.
The principles and operation of the present disclosure may be better understood with reference to the drawings and accompanying descriptions.
Before explaining at least one embodiment of the disclosure in detail, it is to be understood that the disclosure is not limited in its application to the details set forth in the following description or exemplified by the Examples. The disclosure is capable of other embodiments or of being practiced or carried out in various ways. Also, it is to be understood that the phraseology and terminology employed herein is for the purpose of description and should not be regarded as limiting.
In a previously filed patent application (U.S. Publication No. 20140066960, filed Aug. 21, 2013, the entire disclosure of which is hereby incorporated by reference), the disclosure described an angioplasty balloon catheter having an expandable constraining structure positioned over a balloon. The expandable constraining structure is not attached to the balloon but is expanded thereby to constrain balloon inflation and enable isolated balloon regions to protrude from the constraining structure during inflation. This ensures that the balloon applies a uniform force on the vessel wall when inflated and reduces the likelihood of dissections and other trauma.
Although experiments have shown that the balloon catheter of U.S Publication No. 20140066960 is highly effective in dilating stenosed regions and minimizing trauma to the vessel wall, due to its metal constraining structure it has a fairly large packing diameter and limited flexibility and maneuverability through torturous vessels.
In order to traverse these limitations, the present inventors have devised a balloon catheter which is capable of providing the benefits of U.S. Publication No. 20140066960 under high inflation pressures, is easy to manufacture and can be efficiently packed for delivery while being highly maneuverable through torturous vessels. As is further described hereinbelow, such benefits are provided by a fiber grid which is attached to, or integrated into the balloon wall and is configured for modifying the shape of the balloon surface to form pillow-like protrusions upon balloon inflation.
Balloons with integrated or attached fiber grids are known in the art (e.g. U.S. Publication No. 20060271093 or U.S. Publication No. 20050271844). However, such fiber grids are utilized to prevent balloon over-inflation and increase balloon integrity under high inflation pressures and not for modifying the shape of the inflated balloon to form pillow-like balloon protrusions through the grid.
Thus, according to one aspect of the present disclosure, there is provided a system for dilating a stenosed vessel. As used herein, the term vessel refers to any hollow conduit in the body and includes blood vessels such as arteries and veins, lymphatic vessels, GI tract vessels (e.g. intestines), ducts and any body passage, which conducts a biological fluid. As is further described hereinunder, one preferred use of the present system is in angioplasty of arteries such as peripheral (e.g. leg) arteries.
The present system includes a balloon composed of a first material (e.g. first polymer) mounted on a catheter shaft and a plurality of fibers forming a grid-like pattern attached to a surface of the balloon or integrated within a wall thereof. The fibers are composed of a second material (e.g. second polymer) which is preferably stronger and less stretchable than the first material.
As such, inflation of the balloon beyond a predetermined threshold pressure (e.g. above 3 ATMs) stretches the balloon material more than the fibers, forming channels along the balloon surface where the fibers are constrained or fixed and balloon protrusions therebetween where the balloon material is unconstrained. The grid of fibers maintains balloon uniformity (axially and radially) throughout inflation enabling the protrusions (also referred to herein as pillows) to uniformly contact the vessel wall and plaque material thus ensuring uniform force distribution along the treated vessel region and minimizing vessel trauma while effectively dilating the entire plaque region. In addition, since the channels formed by the grid fibers are recessed from the vessel wall when the balloon is inflated, they provide stress relief regions and further reduce the likelihood of trauma.
In order to enable formation of the protrusions and control protrusion height area and shape, one must carefully select the balloon and fiber material, the strength and diameter of the fibers and the shape of the grid formed thereby.
The balloon material is selected based on desired compliance (defined herein as elasticity or tensile modulus) and resistance to rupture (strength). The fiber is selected based on strength and elasticity.
The catheter shaft can be any configuration suitable for use in the desired procedure. For example, in angioplasty procedures the catheter can be configured for over-the-wire or a rapid exchange delivery and can include suitable connectors for wire insertion, inflation and the like at its proximal end. The catheter shaft can be any length and diameter suitable for angioplasty of peripheral, coronary, or cerebral blood vessels. Suitable length (L) and diameter (D) of the balloon can be in the range of about 4-40 mm L, 1.25-5 mm D for coronary applications and 20-300 mm L, 2-12 (or more) mm D for peripheral vessels applications.
The balloon can be a compliant or a semi-compliant balloon fabricated from polyamide, Pebax, polyurethane, polyethylene terephthalate, or similar material and the like at dimensions selected from a range of about 5-300 mm in length and about 2-12 (or more) mm in diameter. The balloon can be cylindrical or any other shape known in the art. For example, when utilized in angioplasty, the balloon can be roughly cylindrical in shape with tapered ends with a length of 5-300 mm and a diameter of 2-12 mm the taper is normally similar or slightly shorter than the balloon diameter. The elasticity of the balloon material can be between 0.0002 to 0.0100 GPa.
The grid can be formed from single filament or multi-filament fibers (of the same or different filaments) that are woven or braided from any material suitable for such purposes. The fibers can be 10-750 microns in thickness, such as in the radial direction, with uniform or variable thickness throughout fiber length (over balloon). For example, the fiber can be thicker at the balloon tapers or legs and thinner at the working length.
The fibers can be made from various polymers (such as polyurethane, polyamide, polyethylene or other) or metals (such as Nitinol or Cobalt chromium alloy or other) or composites thereof, other suitable material. Specific and preferred examples include ultra-high molecular weight polyethylene, polyvinylidene fluoride, and polyethylene terephthalate. A presently preferred material for the fibers is ultra-high molecular weight polyethylene.
Multifilament fibers are typically measured in units of Deniers, which is a unit of measure for the linear mass density of fibers. The linear mass density of the fibers can be 10-100 Deniers, preferably 50 deniers.
The elasticity of the fibers can range from 0.1-500 GPa, preferably 100 GPa.
Braid density of the fibers is also important and is determined by the picks per inch (PPI), i.e. the number of fiber crossovers per inch of balloon length; a high PPI correlates with a high burst pressure. The PPI used to fabricate the grid of the present system is preferably within a range of 2-20, more preferably 6-14.
Several approaches can be used to fabricate the present system. The present system is assembled while the balloon is an inflated or semi-inflated form under a pressure of 0.3-20 ATMs (preferably 0.3-8 ATMs, more preferably 0.3-2 ATMs). The inflation pressure used sets the extent of balloon material stretching which in turn determines the outer diameter of the constrained segment of the balloon and maximum protrusion height of the isolated balloon regions of a fully inflated balloon.
When the balloon is not inflated (or is inflated to a pressure below the threshold), the fiber braid protrudes from the surface of the balloon (
In a 3 mm balloon (which is capable of reaching diameters greater than 3 mm with over inflation), assembly of the fibers is effected over a balloon inflated to about 3 mm in diameter. When the assembled balloon is inflated inside a vessel, protrusions of the isolated balloon regions will for at this diameter, and will gradually increase in height along with inflation. At 3.5 mm in diameter, the height of the isolated balloon regions protruding from the balloon surface will begin at 3.5 mm and gradually increase in height with inflation, typically to about 0.01-0.5 mm in increased height.
The fibers are preferably attached to the balloon surface along the entire length of each fiber. Attachment is effected using an adhesive applied to the fibers or by sandwiching the fibers between two adhesive layers applied to the balloon surface, a base and cover adhesive layer. These layers can be applied via dipping, spraying, or any other approach known in the art. The base layer of the balloon wall can be any flexible adhesive layer that allows for immobilization of the fibers but retains the flexibility of the underlying balloon substrate while the cover layer further immobilizes the grid, protects it from the vessel wall and plaque and enhances vascular wall-gripping.
A smooth cover layer is particularly advantageous when the present balloon catheter is utilized for dilating in-stent restenosis. The cover layer of the present balloon prevents ‘stent jailing’—a phenomenon in which struts of, for example, cutting/scoring balloons, are trapped within stent struts.
Attachment or partial-attachment of the fibers to the balloon surface may be desirable in order to maintain fiber position over the balloon throughout inflation, and thus maintain the shape and size of the isolated balloon regions. If the fibers were free to move the uniformity of balloon protrusions could not be maintained and thus uniform vessel dilation would not be possible. Fixation of the fibers in a specific grid shape is also very important over the balloon tapers where a free wire would tend to slip from its intended position more easily, again resulting in protrusion non-uniformity.
The fibers are braided over the balloon working length at a lead angle as defined by the PPI. The angle can vary from 30-180 degrees. In one embodiment, each isolated balloon region (protruding between channels) is surrounded by four crossing fibers angled at approximately 90 degrees to each other. Since the lead angle is constant and equal for all fibers, the isolated balloon regions formed between the fibers are square/rectangle. At this configuration, the fibers are positioned to resist tension forces applied thereupon by the pressure buildup in the balloon.
In the above example, the fibers are braided lengthwise and radially, however, the present grid can also be formed by helical braiding of fibers over the working length and tapers of the balloon.
An optional top layer can be applied to the balloon following sandwiching of the fiber grid between the base and cover layers. This top layer decreases the tackiness of the balloon and improves its ability to track through a tortuous anatomy and inflate within the vessel site. The top layer can be composed of parylene or any other material commonly known in the art.
Alternatively, the balloon can be coated with a coating following sandwiching of the fiber grid between the base and cover layers. This coating can be a hydrophilic material or a hydrophobic material. The coating decreases the tackiness of the balloon and improves its ability to track through a tortuous anatomy and inflate within the vessel site. The top layer can be composed of silicone, polyurethane, polyvinylpyrrolidone, hyaluronic acid, or any other material commonly known in the art.
When assembled the balloon can be folded in regular folding techniques known in the art. The balloon can be folded to 2-8 pleats, with the pleats being wrapped around the balloon axis as done with plain balloon. The fibers are soft enough to allow such folding.
One specific embodiment of manufacturing process is described hereinbelow:
System 10 includes a catheter shaft 12, which is fabricated from polymer extrusions and includes longitudinal lumens running the length of shaft 12. A first lumen can accommodate a guidewire while a second lumen can serve as an inflation conduit for balloon 20 mounted on a distal portion 14 of shaft 12. Proximal portion 16 of shaft 12 includes a connector 18 having dedicated ports 22 and 24 communicating with the second and first lumens (respectively).
For coronary applications balloon 20 can be between 1.25 to 5.0 mm in diameter and 4 to 40 mm in length (when inflated as shown in
Balloon 20 is attached to distal portion 14 of shaft 12 using approaches well known in the art (e.g. gluing or welding). A grid 30 is integrated into, or glued onto wall 32 of balloon 20 as is described above. Grid 30 is formed from two or more fibers 34 (five radial fibers 35 and four axial fibers 37 shown in
As is shown in
As is mentioned herein, isolated balloon regions 36 contact the plaque in the vessel and apply a uniform force thereto, while channels 40 (which are recessed from the plaque) function as stress relief regions.
Four to seventy two fibers can be positioned around balloon 20 depending on the length and diameter thereof. Fibers 34 can be laid down in any pattern as long as the grid formed thereby includes openings 38 of roughly the same area and shape. For example, fibers 34 can be laid down longitudinally (axially) and radially to form square or rectangular openings 38 (as is shown in
The number of fibers 34 correlates to the density of the braid forming the grid and the number of and area of openings 38 (forming isolated balloon regions 36).
In one embodiment of the present disclosure shown in
In another embodiment of the present disclosure shown in
The total number of isolated balloon regions 36 depends on the balloon length: In the example of
Grid 30 preferably has a variable pitch (fiber 34 angles) over the working length (WL), legs (LG), and tapers (TP) of balloon 20 (
System 10 can be used in angioplasty as follows. System 10 can be guided to the stenosed region over a guide-wire (not shown) using well known angioplasty approaches. Once in position, balloon 20 can be inflated to a point where it channels 40 and isolated balloon regions 36 are formed to apply an outward radial force to the plaque at isolated balloon regions 36 and stress relief regions at channels 40. Once the region is sufficiently dilated, balloon 20 is deflated and system 10 is removed from the body.
Thus, the present disclosure provides a balloon system, which protects the vessel wall from uneven expansion, as well as enables provision of localized higher pressure forces to specific lesion regions that are resistant, such as highly calcified expansion-resistant plaque regions.
Balloon 20 of system 10 and/or grid 30 can be coated with a hydrophilic or hydrophobic coating to enhance lubricity or coated with a drug composition containing, for example, an antiproliferative drug such as sirolimus or paclitaxel using methods well known in the art.
As used herein the term “about” refers to ±10%.
Additional objects, advantages, and novel features of the present disclosure will become apparent to one ordinarily skilled in the art upon examination of the following examples, which are not intended to be limiting.
Reference is now made to the following examples, which together with the above descriptions, illustrate the disclosure in a non-limiting fashion.
Several prototype balloons were constructed according to the teachings of the present disclosure and tested as described below.
Briefly, a nylon balloon was fabricated via blow molding and the balloon was pre-inflated to 0.3 atm. The balloon was dip-coated in a polyurethane adhesive and an ultra-high molecular weight polyethylene multifilament fiber was braided in a diamond pattern over the balloon surface. The balloon was then dip-coated in a second layer of the polyurethane adhesive followed by dip-coating in parylene.
Five types of balloons were constructed, a 6 mm (inflated diameter)×40 mm (inflated length) balloon at two PPI densities of 6, 10 (
The following parameters were tested for each balloon type:
Table 1 below summarizes the results with the 5 tested balloons.
It is appreciated that certain features of the disclosure, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the disclosure, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination.
Although the disclosure has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications, and variations will be apparent to those skilled in the art. Accordingly, it is intended to embrace all such alternatives, modifications, and variations that fall within the spirit and broad scope of the appended claims. All publications, patents, and patent applications mentioned in this specification are herein incorporated in their entirety by reference into the specification, to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated herein by reference. In addition, citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the present disclosure.
This application claims priority benefit under 35 U.S.C. § 119(e) of U.S. Provisional Application No. 62/080,831, filed Nov. 17, 2014, the entirety of which is incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
2701559 | Cooper | Feb 1955 | A |
2854983 | Baskin | Oct 1958 | A |
3045677 | Wallace | Jul 1962 | A |
3467101 | Fogarty et al. | Sep 1969 | A |
3825013 | Craven | Jul 1974 | A |
4327736 | Inoue | May 1982 | A |
4456011 | Warnecke | Jun 1984 | A |
4483340 | Fogarty et al. | Nov 1984 | A |
4637396 | Cook | Jan 1987 | A |
4723549 | Wholey et al. | Feb 1988 | A |
4796629 | Grayzel | Jan 1989 | A |
4921484 | Hillstead | May 1990 | A |
4976711 | Parins et al. | Dec 1990 | A |
4998539 | Delsanti | Mar 1991 | A |
5071407 | Porter et al. | Dec 1991 | A |
5100386 | Inoue | Mar 1992 | A |
5133732 | Wilkor | Jul 1992 | A |
5176693 | Pannek | Jan 1993 | A |
5181911 | Shturman | Jan 1993 | A |
5190058 | Jones et al. | Mar 1993 | A |
5196024 | Barath | Mar 1993 | A |
5222971 | Willard et al. | Jun 1993 | A |
5224945 | Pannek, Jr. | Jul 1993 | A |
5263963 | Garrison et al. | Nov 1993 | A |
5308356 | Blackshear, Jr. et al. | May 1994 | A |
5320634 | Vigil et al. | Jun 1994 | A |
5336178 | Kaplan | Aug 1994 | A |
5336234 | Vigil et al. | Aug 1994 | A |
5344419 | Spears | Sep 1994 | A |
5449372 | Schmaltz et al. | Sep 1995 | A |
5456666 | Campbell et al. | Oct 1995 | A |
5456667 | Ham et al. | Oct 1995 | A |
5460607 | Miyata et al. | Oct 1995 | A |
5484411 | Inderbitzen | Jan 1996 | A |
5501694 | Ressemann et al. | Mar 1996 | A |
5527282 | Segal | Jun 1996 | A |
5556408 | Farhat | Sep 1996 | A |
5562620 | Klein et al. | Oct 1996 | A |
5571086 | Kaplan et al. | Nov 1996 | A |
5607442 | Fischell et al. | Mar 1997 | A |
5609574 | Kaplan et al. | Mar 1997 | A |
5616149 | Barath | Apr 1997 | A |
5620457 | Pinchasik et al. | Apr 1997 | A |
5628746 | Clayman | May 1997 | A |
5628755 | Heller et al. | May 1997 | A |
5643210 | Iacob | Jul 1997 | A |
5643312 | Fischell et al. | Jul 1997 | A |
5695469 | Segal | Dec 1997 | A |
5702410 | Klunder et al. | Dec 1997 | A |
5713863 | Vigil et al. | Feb 1998 | A |
5730698 | Fischell et al. | Mar 1998 | A |
5733303 | Israel et al. | Mar 1998 | A |
5735816 | Lieber et al. | Apr 1998 | A |
5755781 | Jayaraman | May 1998 | A |
5772681 | Leoni | Jun 1998 | A |
5776181 | Lee et al. | Jul 1998 | A |
5797935 | Barath | Aug 1998 | A |
5810767 | Klein | Sep 1998 | A |
5827321 | Roubin et al. | Oct 1998 | A |
5863284 | Klein | Jan 1999 | A |
5868708 | Hart et al. | Feb 1999 | A |
5868719 | Tsukernik | Feb 1999 | A |
5868779 | Ruiz | Feb 1999 | A |
5868783 | Tower | Feb 1999 | A |
5869284 | Cao et al. | Feb 1999 | A |
5904679 | Clayman | May 1999 | A |
5906639 | Rudnick et al. | May 1999 | A |
5919200 | Stambaugh et al. | Jul 1999 | A |
5961490 | Adams | Oct 1999 | A |
5967984 | Chu et al. | Oct 1999 | A |
5987661 | Peterson | Nov 1999 | A |
6013055 | Bampos et al. | Jan 2000 | A |
6036689 | Tu et al. | Mar 2000 | A |
6036708 | Sciver | Mar 2000 | A |
6053913 | Tu et al. | Apr 2000 | A |
6059810 | Brown et al. | May 2000 | A |
6059811 | Pinchasik et al. | May 2000 | A |
6077298 | Tu et al. | Jun 2000 | A |
6102904 | Vigil et al. | Aug 2000 | A |
6106548 | Roubin et al. | Aug 2000 | A |
6129706 | Janacek | Oct 2000 | A |
6156265 | Sugimoto | Dec 2000 | A |
6190403 | Fischell et al. | Feb 2001 | B1 |
6206910 | Berry et al. | Mar 2001 | B1 |
6217608 | Penn | Apr 2001 | B1 |
6235043 | Reiley et al. | May 2001 | B1 |
6241762 | Shanley | Jun 2001 | B1 |
6245040 | Inderbitzen et al. | Jun 2001 | B1 |
6261319 | Kveen et al. | Jul 2001 | B1 |
6309414 | Rolando et al. | Oct 2001 | B1 |
6319251 | Tu et al. | Nov 2001 | B1 |
6334871 | Dor et al. | Jan 2002 | B1 |
6361545 | Macoviak et al. | Mar 2002 | B1 |
6416539 | Hassdenteufel | Jul 2002 | B1 |
6454775 | Demarais et al. | Sep 2002 | B1 |
6540722 | Boyle et al. | Apr 2003 | B1 |
6605107 | Klein | Aug 2003 | B1 |
6616678 | Nishtala et al. | Sep 2003 | B2 |
6626861 | Hart et al. | Sep 2003 | B1 |
6652548 | Evans et al. | Nov 2003 | B2 |
6656351 | Boyle | Dec 2003 | B2 |
6695813 | Boyle et al. | Feb 2004 | B1 |
6702834 | Boylan et al. | Mar 2004 | B1 |
6939320 | Lennox | Sep 2005 | B2 |
6942680 | Grayzel et al. | Sep 2005 | B2 |
7186237 | Meyer et al. | Mar 2007 | B2 |
7357813 | Burgermeister | Apr 2008 | B2 |
7686824 | Konstantino et al. | Mar 2010 | B2 |
7691119 | Farnan | Apr 2010 | B2 |
7708748 | Weisenburgh, II et al. | May 2010 | B2 |
7753907 | DiMatteo et al. | Jul 2010 | B2 |
7803149 | Bates et al. | Sep 2010 | B2 |
7931663 | Farnan et al. | Apr 2011 | B2 |
8172793 | Bates et al. | May 2012 | B2 |
8257305 | Speck et al. | Sep 2012 | B2 |
8388573 | Cox | Mar 2013 | B1 |
8439868 | Speck et al. | May 2013 | B2 |
9179936 | Feld et al. | Nov 2015 | B2 |
9199066 | Konstantino et al. | Dec 2015 | B2 |
9216033 | Feld et al. | Dec 2015 | B2 |
9375328 | Farnan | Jun 2016 | B2 |
9415140 | Speck | Aug 2016 | B2 |
9649476 | Speck et al. | May 2017 | B2 |
20020010489 | Grayzel et al. | Jan 2002 | A1 |
20030023200 | Barbut et al. | Jan 2003 | A1 |
20030040790 | Furst | Feb 2003 | A1 |
20030078606 | Lafontaine et al. | Apr 2003 | A1 |
20030114915 | Mareiro et al. | Jun 2003 | A1 |
20030114921 | Yoon | Jun 2003 | A1 |
20030153870 | Meyer et al. | Aug 2003 | A1 |
20030195609 | Berenstein et al. | Oct 2003 | A1 |
20040034384 | Fukaya | Feb 2004 | A1 |
20040073284 | Bates | Apr 2004 | A1 |
20040143287 | Konstantino et al. | Jul 2004 | A1 |
20040210235 | Deshmukh | Oct 2004 | A1 |
20040210299 | Rogers et al. | Oct 2004 | A1 |
20040230293 | Yip et al. | Nov 2004 | A1 |
20050021071 | Konstantino et al. | Jan 2005 | A1 |
20050125053 | Yachia et al. | Jun 2005 | A1 |
20050271844 | Mapes et al. | Dec 2005 | A1 |
20060008606 | Horn et al. | Jan 2006 | A1 |
20060015133 | Grayzel et al. | Jan 2006 | A1 |
20060085025 | Farnan et al. | Apr 2006 | A1 |
20060259005 | Konstantino et al. | Nov 2006 | A1 |
20060271093 | Holman | Nov 2006 | A1 |
20070073376 | Krolik et al. | Mar 2007 | A1 |
20070173923 | Savage et al. | Jul 2007 | A1 |
20080255508 | Wang | Oct 2008 | A1 |
20090036964 | Heringes et al. | Feb 2009 | A1 |
20090038752 | Weng | Feb 2009 | A1 |
20090105686 | Snow et al. | Apr 2009 | A1 |
20090192453 | Wesselman | Jul 2009 | A1 |
20090227949 | Knapp et al. | Sep 2009 | A1 |
20090240270 | Schneider et al. | Sep 2009 | A1 |
20090319023 | Hildebrand et al. | Dec 2009 | A1 |
20100042121 | Schnieder et al. | Feb 2010 | A1 |
20100234875 | Allex | Sep 2010 | A1 |
20100331809 | Sandhu | Dec 2010 | A1 |
20110071616 | Clarke et al. | Mar 2011 | A1 |
20110172698 | Davies et al. | Jul 2011 | A1 |
20120059401 | Konstantino | Mar 2012 | A1 |
20120083733 | Chappa | Apr 2012 | A1 |
20120245607 | Gershony et al. | Sep 2012 | A1 |
20130046237 | Speck et al. | Feb 2013 | A1 |
20130116655 | Bacino et al. | May 2013 | A1 |
20130190725 | Pacetti | Jul 2013 | A1 |
20130211381 | Feld | Aug 2013 | A1 |
20130218181 | Feld et al. | Aug 2013 | A1 |
20140066960 | Feld et al. | Mar 2014 | A1 |
20150209556 | Timothy | Jul 2015 | A1 |
20160022968 | Feld et al. | Jan 2016 | A1 |
20160058991 | Feld et al. | Mar 2016 | A1 |
20160100964 | Feld et al. | Apr 2016 | A1 |
Number | Date | Country |
---|---|---|
1568165 | Jan 2005 | CN |
0 565 796 | Oct 1993 | EP |
0 623 315 | Nov 1994 | EP |
0 832 608 | Apr 1998 | EP |
1 042 997 | Oct 2000 | EP |
2005-508709 | Apr 2005 | JP |
WO 9805377 | Feb 1998 | WO |
WO 9850101 | Nov 1998 | WO |
WO 2002068011 | Sep 2002 | WO |
WO 2003041760 | May 2003 | WO |
WO 2005020855 | Mar 2005 | WO |
WO 2011112863 | Sep 2011 | WO |
WO 2013114201 | Aug 2013 | WO |
WO 2013119735 | Aug 2013 | WO |
Entry |
---|
Cambridge University Engineering Department's Materials Data Book, 2003 edition, available online May 5, 2017 at http://www-mdp.eng.cam.ac.uk/web/library/enginfo/cueddatabooks/materials.pdf. |
Plastics Materials, J. A., Brydson, sixth edition, 1995, p. 510, available in part online on May 5, 2017 at https://books.google.com/books?id=wmohBQAAQBAJ&lpg=PA510&ots=G_4Q-OMpB4&dq=young's%20modulus%20of%20PEBAx&pg=PA510#v=onepage&q=young's%20modulus%20of%20PEBAx&f=false. |
Plastics Materials, J. A., Brydson, sixth edition, 1995, p. 510, available in relevant part online on Aug. 21, 2017 at https://books.google.com/books?id=wmohBQAAQBAJ&lpg=PA510&ots=G_4Q-OMpB4&dq=young's%20modulus%20of%20PEBAx&pg=PA510#v=onepage&q=young's%20modulus%20of%20PEBAx&f=false. |
Cambridge University Engineering Department's Materials Data Book, 2003 edition, available online Aug. 21, 2017 at http://www-mdp.eng.cam.ac.uk/web/library/enginfo/cueddatabooks/materials.pdf. |
Bearing Works, (PTFE) Polytetrafluoroethylene material specifications sheet, available online Feb. 11, 2018 at https://www.bearingworks.com/uploaded-assets/pdfs/retainers/ptfe-datasheet.pdf. |
Plastics Materials, J. A., Brydson, sixth edition, 1995, p. 510, available in part online on Feb. 12, 2018 at https://books.google.com/books?id=wmohBQAAQBAJ&lpg=PA510&ots=G_4Q-OMpB4&dq=young's%20modulus%20of%20PEBAx&pg=PA510#v=onepage&q=young's%20modulus%20of%20PEBAx&f=false. |
Plastics Materials, J. A., Brydson, sixth edition, 1995, p. 510, available in relevant part online on Jun. 12, 2018 at https://books.google.com/books?id=wmohBQAAQBAJ&lpg=PA510&ots=G_4Q-OMpB4&dq=young's%20modulus%20of%20PEBAx&pg=PA510#v=onepage&q=young's%20modulus%20of%20PEBAx&f=false. |
Cambridge University Engineering Department, Materials Data Book, 2003 edition, available online Jun. 12, 2018 at http://www-mdp.eng.cam.ac.uk/web/library/enginfo/cueddatabooks/materials.pdf. |
AngioSculpt XL PT Scoring Balloon Catheter Brochure, AngioScore, Inc., Rev. C, May 2013. |
Kadish, A., et al. “Mapping of Atrial Activation With a Noncontact, Multielectrode Catheter in Dogs,” Circulation: Journal of the American Heart Association, (Apr. 1999) 99: 1906-1913. |
International Search Report for Appl. No. PCT/IB2015/058802, dated Feb. 5, 2016 in 17 pages. |
Number | Date | Country | |
---|---|---|---|
20160136397 A1 | May 2016 | US |
Number | Date | Country | |
---|---|---|---|
62080831 | Nov 2014 | US |